Rocket Pharmaceuticals, Inc. CEO Gaurav Shah filed a Form 4 on November 17, 2026, disclosing the sale of 3,020 shares of common stock on November 13, 2026, to cover tax withholding obligations arising from the vesting of restricted stock units.
Key Highlights
- Transaction date: 3,020 shares of common stock were disposed of on November 13, 2026.
- Sale price: Shares were sold at $2.25 per share.
- Purpose: According to the filing, the shares were sold "in order to pay tax withholding obligations in connection with the vesting of RSUs."
- Direct beneficial ownership following transaction: 1,053,574 shares, which the filing notes includes RSUs that convert to common stock on a one-for-one basis.
- Indirect holdings: 207,897 shares held by spouse and 198,341 shares held by the Gaurav D. Shah Irrevocable Trust.
- Reporting person role: Gaurav Shah is identified as CEO of Rocket Pharmaceuticals, Inc.
CEO Shah's RSU Tax-Withholding Sale at Rocket Pharmaceuticals
According to the Form 4 filed with the SEC on November 17, 2026, Gaurav Shah, the CEO of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), reported a disposition of 3,020 shares of common stock on November 13, 2026, at a price of $2.25 per share. The filing states the transaction code was "S" and that the shares were disposed of to satisfy tax withholding obligations connected to the vesting of restricted stock units.
Following the reported transaction, the filing discloses that Shah directly owns 1,053,574 shares of common stock, a figure the filing notes includes RSUs that convert to common stock on a one-for-one basis. In addition to his direct holdings, the filing records 207,897 shares held indirectly by his spouse and 198,341 shares held indirectly through the Gaurav D. Shah Irrevocable Trust.
The Form 4 was signed by Martin Wilson as attorney-in-fact for Gaurav Shah and submitted on November 17, 2026. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
Rocket Pharmaceuticals CEO Gaurav Shah disclosed the sale of 3,020 common shares at $2.25 each on November 13, 2026, solely to cover RSU-vesting tax obligations, leaving him with 1,053,574 directly held shares plus additional indirect holdings.



Please wait processing your request...